期刊文献+

介入治疗与神经内分泌及纤溶状态的关系

Relationship Among Interventional Therapy with Neuroendocrine System and Fibrinolytic System
暂未订购
导出
摘要 先天性心脏病的代偿期与失代偿期存在着不同程度的交感神经系统的激活和神经内分泌系统的紊乱,以及纤溶系统功能失衡。因此多种缩血管物质如血管紧张素Ⅱ(Ang II)、内皮素-1(ET-1)、去甲肾上腺素(NA)等生成与释放增加,而舒血管物质如一氧化碳(NO)、利尿钠肽等生成或作用降低。这些缩血管物质不仅加剧血流动力学的紊乱,而且某些物质还可以直接作用于心脏,损伤心肌细胞,诱导心肌细胞肥大与凋亡,促使先天性心脏病(CHD)患者的病情加重;同时CHD患者存在血管内皮细胞和血小板的功能障碍及凝血、抗凝系统的异常,可导致血液处于血栓前状态。而介入治疗(CHD封堵术)后,心内左向右分流被完全阻断,因此,CHD患者的交感神经系统和神经内分泌系统,以及纤溶系统的功能逐渐恢复正常。 The different degree activation of sympathetic nervous system and disturbances of neuroendocrine system and fibrinolytic system present in compensatory stage and decompensatory stage of congenital heart disease ( CHD). Formation and replease of the varied vasoconstrietive materials is increased, including angiotensin-Ⅱ , endothelin-Ⅰ , and noradrenaline, etc. Inversely, formation and action of the vasodilative materials is decreased, such as nitric oxide, and natriuretic peptide, etc. Not only the vasoconstrictive materials lead to exacerbation of hemodynamic disorder, but also some of them directly act on the heart, and injure cardiac muscle cells, induce hypertrophy and apeptosis of myocanlial cells, and then promote exacerbation of congenital heart disease. At the same time, functional disturbance of vascular endothelial cells and blood plague, and abnormality of the blood coagulation and anticoagulant mechanisms can cause the blood in status pre-thrombosis. The blood from left to right shunt in the heart is entirely blacked by interventional therapy, then the function of the sympathetic nervous system, neuroendocrine system and fibrinolytic system gradually recovery normal.
出处 《医学综述》 2006年第4期244-246,共3页 Medical Recapitulate
基金 广西科技攻关项目(桂科攻0472002-30)
关键词 介入治疗 先天性心脏病 肾素-血管紧张素系统 血浆内皮素 纤溶状态 Interventional thempy Congestive heart failwre Renin-angiotension system Plasma endothelin Fibrinolytie status
  • 相关文献

参考文献14

  • 1Aidan P, Sharma R, Paul R, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease[ J ]. Circulation, 2002,106(4) : 92-99.
  • 2Dietz R, von-Harsdorf R, Gross M, et al. Angiotensin Ⅱ and coronary artery disease, congestive heart failure and sudden cardiac death [ J ].Basic Res Cardiol, 1998,93[Suppl 2] :s101-108.
  • 3罗学群,林红,覃有振,李运泉,魏民新,陆堃.卡托普利对左向右分流先天性心脏病肺动脉高压患者的血液动力学作用[J].中国现代医学杂志,2000,10(1):10-11. 被引量:9
  • 4Chung O, Csikos T, Unger T. Angiotensin Ⅱ receptor pharmacology and AT2 receptors C [J]. J Hum Hypertens, 1999,12[ Suppl 1 ] : S11-20.
  • 5Jalowy A, Schulz R, Dorge H, et al.Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-roceptor activation,bradykinin and prostaglandings in pigs[J].J Am Coll Cardiol,2003,32(6) : 1787-1796.
  • 6李爱萍,陈光辉,李天德,刘航,易军,王莉.不同水平干预对AngII作用心肌细胞活力的影响[J].军医进修学院学报,2004,25(4):252-254. 被引量:8
  • 7Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor produced by vascular endothelial cells [J]. Nature, 1998,332(3) :411-415.
  • 8Galie N, Manes A, Branzi A, et al. The endothelin system in pulmonary arterial hypertension[J]. Cardiovasc Res,2004,61(3):227-237.
  • 9Wang DL, Tang CC, Wang BS, et al. Cyclical strain increase endothelin-1 secretion and gene expression in human endothelial cells[J]. Biophys Res Commun. 1993,195(2) : 1050.
  • 10周文斌.先心病肺高压与血管内皮受损[J].中国现代医学杂志,2001,11(6):34-37. 被引量:2

二级参考文献23

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部